Role of mycotoxins in the pathobiology of autism: A first evidence

References

• Schaaf C, Zoghbi H. Solving the autism puzzle a few pieces at a time. Neuron 2011;70(5):806–8. doi: 10.1016/j.neuron.2011.05.025
   PubMed Web of Science ®Google Scholar
• Cohen D, Pichard N, Tordjman S, Baumann C, Burglen L, Excoffier E, et al. Specific genetic disorders and autism: clinical contribution towards their identification. J Autism Dev Disord 2005;35:103–16. doi: 10.1007/s10803-004-1038-2
   PubMed Web of Science ®Google Scholar
• Fulceri F, Morelli M, Santocchi E, Cena H, Del Bianco T, Narzisi A, et al. Gastrointestinal symptoms and behavioral problems in preschoolers with Autism Spectrum Disorder. Dig Liver Dis 2016;48(3):248–54. doi: 10.1016/j.dld.2015.11.026
   PubMedGoogle Scholar
• Christensen D, Baio J, Braun K, Bilder D, Charles J, Constantino J, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years — autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR Surveill Summ 2016;65(3):1–23. doi: 10.15585/mmwr.ss6503a1
   PubMed Web of Science ®Google Scholar
• Deth R, Muratore C, Benzecry J, Power-Charnitsky VA, Waly M. How environmental and genetic factors combine to cause autism: a redox/methylation hypothesis. NeuroToxicology 2008;29(1):190–201. doi: 10.1016/j.neuro.2007.09.010
   PubMed Web of Science ®Google Scholar
• Werling D, Geschwind D. Understanding sex bias in autism spectrum disorder. Proc Natl Acad Sci 2013;110(13):4868–9. doi: 10.1073/pnas.1301602110
   PubMed Web of Science ®Google Scholar
• Kinney DK, Barcha DH, Chayka B, Napoleon S, Munir KM. Environmental risk factors for autism: do they help cause de novo genetic mutations that contribute to the disorder? Med Hypotheses 2010;74(1):102–6. doi:10.1016/j.mehy.2009.07.052 doi: 10.1016/j.mehy.2009.07.052
   PubMed Web of Science ®Google Scholar
• Williams JH, Phillips TD, Jolly PE, Stiles JK, Jolly CM, Aggarwal D. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventions. Am J Clin Nutr 2004;80:1106–22. doi: 10.1093/ajcn/80.5.1106
   PubMed Web of Science ®Google Scholar
• Wild CP, Gong YY. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis 2010;31(1):71–82. doi:10.1093/carcin/bgp264 doi: 10.1093/carcin/bgp264
   PubMed Web of Science ®Google Scholar
• FAO. (1988). Jelinek CF. Distribution of mycotoxin – an analysis of worldwide commodities data, including data from FAO/WHO/UNEP food contamination monitoring programme. Joint FAO/WHO/UNEP Second International Conference on Mycotoxins. Bangkok, Thailand, September 28 to October 3, 1987.
   Google Scholar
• Ohta K, Maekawa M, Katagiri R, Ueta E, Naruse I. Genetic susceptibility in the neural tube defects induced by ochratoxin A in the genetic arhinencephaly mouse, Pdn/Pdn. Congenit Anom (Kyoto) 2006;46(3):144–8. doi: 10.1111/j.1741-4520.2006.00117.x
   PubMedGoogle Scholar
• Paradells S, Rocamonde B, Llinares C, Herranz-Pérez V, Jimenez M, Garcia-Verdugo JM, et al. Neurotoxic effects of ochratoxin A on the subventricular zone of adult mouse brain. J Appl Toxicol 2015;35(7):737–51. doi:10.1002/jat.3061.PubMedPMID:25256750 doi: 10.1002/jat.3061
   PubMed Web of Science ®Google Scholar
• Kunio D, Koji U. Mechanisms of mycotoxin-induced neurotoxicity through oxidative stress-associated pathways. Int J Mol Sci 2011;12:5213–37. doi:10.3390/ijms12085213 doi: 10.3390/ijms12085213
   PubMed Web of Science ®Google Scholar
• Li Q, Zhou JM. The microbiota-gut-brain axis and its potential therapeutic role in autism spectrum disorder. Neuroscience 2016;324:131–9. doi:10.1016/j.neuroscience.2016.03.013 doi: 10.1016/j.neuroscience.2016.03.013
   PubMed Web of Science ®Google Scholar
• Marasas WFO, Riley RT, Hendricks KA, Stevens VL, Sadler TW, Gelineau-van Waes J, et al. Fumonisins disrupt sphingolipid metabolism, folate transport, and neural tube development in embryo culture and in vivo: a potential risk factor for human neural tube defects among populations consuming fumonisin-contaminated maize. J Nutr 2004;134:711–6. doi: 10.1093/jn/134.4.711
   PubMed Web of Science ®Google Scholar
• Paroni R, Fermo I, Molteni L, Folini L, Pastore MR, Mosca A, et al. Lactulose and mannitol intestinal permeability detected by capillary electrophoresis. J Chromatogr B 2006;834:183–7. doi: 10.1016/j.jchromb.2006.02.050
   PubMed Web of Science ®Google Scholar
• Commission Regulation (EC). 401/2006 of 23 February 2006 laying down the methods of sampling and analysis for the official control of the levels of mycotoxins in foodstuffs. Official Journal of the European Union L. 70/12;9.3.2006.
   Google Scholar
• Beom SS, Seok HH, Sang WH, Hyoung JK, Jong BL, Hae-Seong Y, et al. Determination of zearalenone by liquid chromatography/tandem mass spectrometry and application to a pharmacokinetic study LC/MS/MS analysis of zearalenone. Biomed Chromatogr 2009;23:1014–21. doi:10.1002/bmc.1217 doi: 10.1002/bmc.1217
   PubMed Web of Science ®Google Scholar
• Bielawski J, Szulc ZM, Hannun YA, Bielawska A. Simultaneous quantitative analysis of bioactive sphingolipids by high-performance liquid chromatography-tandem mass spectrometry. Methods 2006;39(2):82–91. doi: 10.1016/j.ymeth.2006.05.004
   PubMed Web of Science ®Google Scholar
• Heyndrickx E, Sioen I, Huybrechts B, Callebaut A, De Henauw S, De Saeger S. Human biomonitoring of multiple mycotoxins in the Belgian population: results of the BIOMYCO study. Environ Int 2015;84:82–9. doi:10.1016/j.envint.2015.06.011 doi: 10.1016/j.envint.2015.06.011
   PubMed Web of Science ®Google Scholar
• Shephard GS, Van Der Westhuizen L, Sewram V. Biomarkers of exposure to fumonisin mycotoxins: a review. Food Addit Contam 2007;24(10):1196–201. doi: 10.1080/02652030701513818
   PubMed Web of Science ®Google Scholar
• Duringer J, Fombonne E, Craig M. No association between mycotoxin exposure and autism: a pilot case-control study in school-aged children. Toxins 2016;8(7):224. doi: 10.3390/toxins8070224
   Web of Science ®Google Scholar
• Waxman DJ, Holloway MG. Sex differences in the expression of hepatic drug metabolizing enzymes. Mol Pharmacol 2009;76(2):215–28. doi:10.1124/mol.109.056705 doi: 10.1124/mol.109.056705
   PubMed Web of Science ®Google Scholar
• Mor F, Kilic MA, Ozmen O, Yilmaz M, Eker I, Uran K. The effects of orchidectomy on toxicological responses to dietary ochratoxin A in Wistar rats. Exp Toxicol Pathol 2014;66(5–6):267–75. doi:10.1016/j.etp.2014.04.002 doi: 10.1016/j.etp.2014.04.002
   PubMed Web of Science ®Google Scholar
• Ueta E, Kodama M, Sumino Y, Kurome M, Ohta K, Katagiri R, et al. Gender-dependent differences in the incidence of ochratoxin A-induced neural tube defects in the Pdn/Pdn mouse. Congenit Anom (Kyoto) 2010;50(1):29–39. doi:10.1111/j.1741-4520.2009.00255.x doi: 10.1111/j.1741-4520.2009.00255.x
   PubMed Web of Science ®Google Scholar
• Zanic-Grubisić T, Zrinski R, Cepelak I, Petrik J, Radić B, Pepeljnjak S. Studies of ochratoxin A-induced inhibition of phenylalanine hydroxylase and its reversal by phenylalanine. Toxicol Appl Pharmacol 2000;167(2):132–9. doi: 10.1006/taap.2000.8987
   PubMed Web of Science ®Google Scholar
• Gunaydin LA, Deisseroth K. Dopaminergic dynamics contributing to social behavior. Cold Spring Harb Symp Quant Biol 2014;79:221–7. doi:10.1101/sqb.2014.79.024711 doi: 10.1101/sqb.2014.79.024711
   PubMedGoogle Scholar
• Saad K, Hammad E, Abdel-Rahman A, Sobhy K. Autistic symptoms in late diagnosed phenylketonuric children in upper Egypt. J Neurol Res North Am 2013;3–4:122–9.
   Google Scholar
• Stachurska A, Ciesla M, Kozakowska M, Wolffram S, Boesch-Saadatmandi C, Rimbach G, et al. Cross-talk between microRNAs, nuclear factor E2-related factor 2, and heme oxygenase-1 in ochratoxin A-induced toxic effects in renal proximal tubular epithelial cells. Mol Nutr Food Res 2013;57(3):504–15. doi:10.1002/mnfr.201200456 doi: 10.1002/mnfr.201200456
   PubMed Web of Science ®Google Scholar
• Dai Q, Zhao J, Qi X, Xu W, He X, Guo M, et al. MicroRNA profiling of rats with ochratoxin A nephrotoxicity. BMC Genomics 2014;15(1):333. doi:10.1186/1471-2164-15-333 doi: 10.1186/1471-2164-15-333
   PubMed Web of Science ®Google Scholar
• Edbauer D, Neilson JR, Foster KA, Wang CF, Seeburg DP, Batterton MN, et al. Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132. Neuron 2010;65:373–84. doi: 10.1016/j.neuron.2010.01.005
   PubMed Web of Science ®Google Scholar
• Jin J, Cheng Y, Zhang Y, Wood W, Peng Q, Hutchison E, et al. Interrogation of brain miRNA and mRNA expression profiles reveals a molecular regulatory network that is perturbed by mutant huntingtin. J Neurochem 2012;123(4):477–90. doi:10.1111/j.1471-4159.2012.07925.x doi: 10.1111/j.1471-4159.2012.07925.x
   PubMed Web of Science ®Google Scholar
• Hansen KF, Sakamoto K, Wayman GA, Impey S, Obrietan K, Dawson TM. Transgenic miR132 alters neuronal spine density and impairs novel object recognition memory. PLoS ONE 2010;5(11):e15497. doi:10.1371/journal.pone.0015497 doi: 10.1371/journal.pone.0015497
   PubMed Web of Science ®Google Scholar
• Abu-Elneel K, Liu T, Gazzaniga FS, Nishimura Y, Wall DP, Geschwind DH, et al. Heterogeneous dysregulation of microRNAs across the autism spectrum. Neurogenetics 2008;9(3):153–61. doi:10.1007/s10048-008-0133-5 doi: 10.1007/s10048-008-0133-5
   PubMed Web of Science ®Google Scholar
• Sarachana T, Zhou R, Chen G, Manji HK, Hu VW. Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines. Genome Med 2010;2(4):23. doi:10.1186/gm144 doi: 10.1186/gm144
   PubMed Web of Science ®Google Scholar
• Lyu JW, Yuan B, Cheng TL, Qiu ZL, Zhou WH. Reciprocal regulation of autism-related genes MeCP2 and PTEN via microRNAs. Sci Rep 2016;4(6):20392. doi:10.1038/srep20392 doi: 10.1038/srep20392
   Web of Science ®Google Scholar
• Chou C, Chang N, Shrestha S, Hsu S, Lin Y, Lee W, et al. miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res 2016;44(D1):D239–47. doi: 10.1093/nar/gkv1258
   PubMed Web of Science ®Google Scholar
• Kumar RA, Christian SL. Genetics of autism spectrum disorders. Curr Neurol Neurosci Rep 2009;9(3):188–97. doi: 10.1007/s11910-009-0029-2
   PubMed Web of Science ®Google Scholar
• Mezzelani A, Landini M, Facchiano F, Raggi ME, Villa L, Molteni M, et al. Environment, dysbiosis, immunity and sex-specific susceptibility: a translational hypothesis for regressive autism pathogenesis. Nutr Neurosci 2015;18(4):145–61. doi:10.1179/1476830513Y.0000000108 doi: 10.1179/1476830513Y.0000000108
   PubMed Web of Science ®Google Scholar
• Mayer EA, Padua D, Tillisch K. Altered brain-gut axis in autism: comorbidity or causative mechanisms? Bioessays 2014;36:933–9. doi:10.1002/bies.201400075 doi: 10.1002/bies.201400075
   PubMed Web of Science ®Google Scholar
• Isolauri E, Rautava S, Kalliomäki M. Food allergy in irritable bowel syndrome: new facts and old fallacies. Gut 2004;53(10):1391–3. doi: 10.1136/gut.2004.044990
   PubMed Web of Science ®Google Scholar
• Cai C, Shen J, Zhao D, Qiao Y, Xu A, Jin S, et al. Serological investigation of food specific immunoglobulin G antibodies in patients with inflammatory bowel diseases. PLoS ONE 2014;9(11):e112154. doi:10.1371/journal.pone.0112154 doi: 10.1371/journal.pone.0112154
   PubMed Web of Science ®Google Scholar
• Ligaarden SC, Lydersen S, Farup PG. Igg and IgG4 antibodies in subjects with irritable bowel syndrome: a case control study in the general population. BMC Gastroenterol 2012;12:667. doi:10.1186/1471-230X-12-166.
   Web of Science ®Google Scholar
• Lewis RE, Wiederhold NP, Chi J, Han XY, Komanduri KV, Kontoyiannis DP, et al. Detection of gliotoxin in experimental and human aspergillosis. Infect Immun 2005;73:635–7. doi: 10.1128/IAI.73.1.635-637.2005
   PubMed Web of Science ®Google Scholar
• Solfrizzo M, Avantaggiato G, Visconti A. Rapid method to determine sphinganine/sphingosine in human and animal urine as a biomarker for fumonisin exposure. J Chromatogr B Biomed Sci Appl 1997;692(1):87–93. doi: 10.1016/S0378-4347(96)00502-6
   PubMed Web of Science ®Google Scholar
• Pineiro M, Asp NG, Reid G, Macfarlane S, Morelli L, Brunser O, et al. FAO technical meeting on prebiotics. J Clin Gastroenterol 2008;42(Suppl 3 Pt 2):S156–9. doi: 10.1097/MCG.0b013e31817f184e
   PubMed Web of Science ®Google Scholar
• Barrett E, Ross RP, O’Toole PW, Fitzgerald GF, Stanton C. γ-Aminobutyric acid production by culturable bacteria from the human intestine. J Appl Microbiol 2012;113(2):411–7. doi:10.1111/j.1365-2672.2012.05344.x. Epub 2012 Jun 15. Erratum in: J Appl Microbiol 2014;116(5):1384–6. doi: 10.1111/j.1365-2672.2012.05344.x
   PubMed Web of Science ®Google Scholar
• Guo M, Huang K, Chen S, Qi X, He X, Cheng WH, et al. Combination of metagenomics and culture-based methods to study the interaction between ochratoxin a and gut microbiota. Toxicol Sci 2014;141(1):314–23. doi:10.1093/toxsci/kfu128 doi: 10.1093/toxsci/kfu128
   PubMed Web of Science ®Google Scholar
• Critchfield JW, van Hemert S, Ash M, Mulder L, Ashwood P. The potential role of probiotics in the management of childhood autism spectrum disorders. Gastroenterol Res Pract 2011;2011:1–8. doi:10.1155/2011/161358 doi: 10.1155/2011/161358
   Web of Science ®Google Scholar